[1] BEYRANVAND M R, FARROKHI S, PEYVANDI H, et al. The effects of amiodarone prophylaxis on cardiac dysrhythmia in acute aluminium phosphide poisoning[J]. Arh Hig Rada Toksikol, 2019, 70(1): 49-53. DOI:10.2478/aiht-2019-70-3162.
[2] BOYCE B A B, YEE B H. Incidence and severity of phlebitis in patients receiving peripherally infused amiodarone[J]. Crit Care Nurse, 2012, 32(4): 27-34. DOI:10.4037/ccn2012139.
[3] ADELBORG K, EBBEHØJ E, NIELSEN J C, et al. Treatment with amiodarone[J]. Ugeskrift Laeger, 2015, 177(24): 1168-1171.
[4] SPIERING M. Peripheral amiodarone-related phlebitis: an institutional nursing guideline to reduce patient harm[J]. J Infus Nurs, 2014, 37(6): 453-460. DOI: 10.1097/nan.0000000000000072.
[5] 陈娇娇, 王琴. 可达龙静脉注射所致静脉炎的护理进展[J]. 当代护士(上旬刊), 2018, 25(12): 6-8. DOI: 10.3969/j.issn.1006-6411.2018.12.003.
[6] GROLL D, DAVIES B, MAC DONALD J, et al. Evaluation of the psychometric properties of the phlebitis and infiltration scales for the assessment of complications of peripheral vascular access devices[J]. J Infus Nurs, 2010, 33(6): 385-390. DOI: 10.1097/nan.0b013e3181f85a73.
[7] NORTON L, OTTOBONI L K, VARADY A, et al. Phlebitis in amiodarone administration: incidence, contributing factors, and clinical implications[J]. Am J Crit Care, 2013, 22(6): 498-505. DOI: 10.4037/ajcc2013460.
[8] 李玮, 张俊, 乔燕舞, 等. 高浓度胺碘酮静脉泵入与静脉炎关系的临床研究[J]. 心血管康复医学杂志, 2004, 13(6): 594-595. DOI: 10.3969/j.issn.1008-0074.2004.06.040.
[9] ORAGANO C A, PATTON D, MOORE Z. Phlebitis in intravenous amiodarone administration: incidence and contributing factors[J]. Crit Care Nurse, 2019, 39(1): e1-e12. DOI: 10.4037/ccn2019381.
[10] AYAT-ISFAHANI F, PASHANG M, DAVOUDI B, et al. Effects of injection-site splinting on the incidence of phlebitis in patients taking peripherally infused amiodarone: a randomized clinical trial[J]. J Vasc Nurs, 2017, 35(1): 31-35. DOI: 10.1016/j.jvn.2016.11.001.
[11] EPPERT H D, GODDARD K B. Administration of amiodarone during resuscitation of ventricular arrhythmias[J]. J Emerg Nurs, 2010, 36(1): 26-28. DOI: 10.1016/j.jen.2009.05.022.
[12] 梁红玉. 护理干预预防盐酸胺碘酮致静脉炎的效果观察[J]. 心电图杂志(电子版), 2018, 7(3): 155-156.
[13] 罗凤莺, 罗新. 综合护理干预预防微量泵持续泵入胺碘酮所致静脉炎的分析[J]. 实用临床护理学电子杂志, 2017, 2(48): 29-30. DOI: 10.3969/j.issn.2096-2479.2017.48.023.
[14] 卢芳芳, 任璟璟. 两种护理干预对盐酸胺碘酮所致静脉炎的效果观察[J]. 中西医结合心血管病电子杂志, 2019, 7(3): 88-89. DOI: 10.16282/j.cnki.cn11-9336/r.2019.03.064.
[15] 谢艳萍, 杨柳, 刘慧颖, 等. 常温下湿敷硫酸镁与盐酸消旋山莨菪碱混悬液治疗静脉输液外渗临床护理研究[J]. 临床医药文献电子杂志, 2019, 6(46): 100. DOI: 10.16281/j.cnki.jocml.2019.46.080.
[16] 刘海霞, 杨德英, 文贵芳. 硫酸镁湿热敷治疗静脉输注可达龙所致血栓性静脉炎的效果及护理观察[J]. 中国卫生产业, 2014, 11(28): 100-102. DOI: 10.16659/j.cnki.1672-5654.2014.28.032.
[17] 邓婉娣, 宋秀婵. 两种方法治疗可达龙导致静脉炎的疗效比较[J]. 现代医院, 2014, 14(4): 91-92. DOI: 10.3969/j.issn.1671-332X.2014.04.037.
[18] 彭利芳. 新鲜土豆薄膜治疗可达龙注射液所致静脉炎的效果研究[J]. 当代护士(上旬刊), 2019, 26(4): 138-140. DOI: 10.3969/j.issn.1006-6411.2019.04.065.
[19] 刘春晖, 孙晓红, 张智容. 喜疗妥预防胺碘酮所致静脉炎的护理体会[J]. 中国中医药咨讯, 2010, 2(30): 26-27.
[20] 加美拉·托尔地, 史超, 玛丽亚尔·斯拉木. 预防性外敷喜疗妥对可达龙致静脉炎的效果评价[J]. 世界最新医学信息文摘, 2016, 16(52): 147-148.
[21] 杨萍萍, 张敏, 张淑玲. 喜疗妥联合康惠尔透明贴防治可达龙所致静脉炎的疗效观察[J]. 中国现代药物应用, 2014, 8(18): 119-121. DOI: 10.14164/j.cnki.cn11-5581/r.2014.18.313.
[22] 刘芳, 常芸, 贾若雅, 等. 两种方法防治胺碘酮相关静脉炎的效果[J]. 现代医学, 2016, 44(2): 250-251. DOI: 10.3969/j.issn.1671-7562.2016.02.031.
[23] 詹荷妹, 严雪婷, 叶笑萍. 水胶体敷料预防输注七叶皂苷钠所致静脉炎效果分析[J]. 黑龙江中医药, 2019, 48(4): 180-181.
[24] 郑若菲, 王淑玉. 两种方法治疗盐酸胺碘酮注射液所致静脉炎的临床研究[J]. 海峡药学, 2015, 27(12): 191-192. DOI: 10.3969/j.issn.1006-3765.2015.12.103.
[25] BAGHERI-NESAMI M, SHOROFI S A, HASHEMI-KAROIE S Z, et al. The effects of sesame oil on the prevention of amiodarone-induced phlebitis[J]. Iran J Nurs Midwifery Res, 2015, 20(3): 365-370.
[26] SHARIFI-ARDANI M, YEKEFALLAH L, ASEFZADEH S, et al. Efficacy of topical chamomile on the incidence of phlebitis due to an amiodarone infusion in coronary care patients: a double-blind, randomized controlled trial[J]. J Integr Med, 2017, 15(5): 373-378. DOI: 10.1016/s2095-4964(17)60358-3. |
